KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 10,608 Value ($000) $209 Avg Close — Range —
Q4 2023
Shares 10,608 Value ($000) $186 Avg Close — Range —
Q3 2023
Shares 10,608 Value ($000) $184 Avg Close — Range —
Q2 2023
Shares 10,608 Value ($000) $114 Avg Close — Range —
Q1 2023
Shares 10,608 Value ($000) $114 Avg Close — Range —
Q4 2022
Shares 30,008 Value ($000) $450 Avg Close — Range —
Q3 2022
Shares 30,008 Value ($000) $385,302 Avg Close — Range —
Q2 2022
Shares 35,490 Value ($000) $343,898 Avg Close — Range —
Q1 2022
Shares 35,490 Value ($000) $352,771 Avg Close — Range —
Q4 2021
Shares 35,490 Value ($000) $417,717 Avg Close — Range —
Q3 2021
Shares 35,490 Value ($000) $404,231 Avg Close — Range —